Cargando…
Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a current global threat for which there is an urgent need to search for an effective therapy. The transmembrane spike (S) glycoprotein of SARS-CoV-2 directly binds to the host angiotensin-converting...
Autores principales: | Feng, Siqin, Luan, Xiaodong, Wang, Yifei, Wang, Hui, Zhang, Zhiyu, Wang, Yiyang, Tian, Zhuang, Liu, Meixi, Xiao, Ying, Zhao, Yong, Zhou, Ruilin, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290210/ https://www.ncbi.nlm.nih.gov/pubmed/32540428 http://dx.doi.org/10.1016/j.meegid.2020.104419 |
Ejemplares similares
-
Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report
por: Feng, Siqin, et al.
Publicado: (2022) -
Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
por: Wan, Ziqi, et al.
Publicado: (2023) -
Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation
por: Liu, Honghong, et al.
Publicado: (2020) -
Eltrombopag in Good's Syndrome
por: Kristiansen, Håvard Anton, et al.
Publicado: (2014) -
Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein
por: Zhu, Yuying, et al.
Publicado: (2020)